MARKET

HELP

HELP

Cybin Inc
NASDAQ
5.31
-0.03
-0.56%
After Hours: 5.34 +0.03 +0.57% 19:26 05/08 EDT
OPEN
5.36
PREV CLOSE
5.34
HIGH
5.44
LOW
5.16
VOLUME
619.73K
TURNOVER
--
52 WEEK HIGH
9.83
52 WEEK LOW
4.290
MARKET CAP
265.69M
P/E (TTM)
-1.4692
1D
5D
1M
3M
1Y
5Y
1D
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Benzinga · 21h ago
Helus Pharma Partners With TARA Mind to Boost Phase 3 Depression Trial in Veterans After U.S. Executive Order
TipRanks · 4d ago
Weekly Report: what happened at HELP last week (0427-0501)?
Weekly Report · 5d ago
Helus Pharma CEO to Spotlight Mental Health Innovation at 29th Milken Global Conference
TipRanks · 04/30 20:17
Psychedelic: FDA awards Compass Pathways priority review voucher
TipRanks · 04/30 18:56
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
Barchart · 04/30 18:17
Cybin’s Helus Pharma joins Milken Institute Global Conference panel on health innovation
PUBT · 04/30 11:37
Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference
Barchart · 04/30 06:30
More
About HELP
Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N, N-dimethyltryptamine (DMT) and dDMT programs create a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. CYB003 moves to Phase III and CYB004 moves to Phase II.CYB005 is in Preclinical stage. It has an intellectual property portfolio in the psychedelic drug development sector with over 80 patents granted and over 230 patent applications pending. The Company operates in Canada, the United States, the United Kingdom, the Netherlands, and Ireland.

Webull offers Cybin Inc stock information, including NASDAQ: HELP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HELP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HELP stock methods without spending real money on the virtual paper trading platform.